NCT05022784View on ClinicalTrials.gov

Adherence to Nintedanib Among Idiopathic Pulmonary Fibrosis Patients

CompletedOBSERVATIONAL
Enrollment

1,798

Participants

Timeline

Start Date

August 23, 2021

Primary Completion Date

December 30, 2021

Study Completion Date

December 30, 2021

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

Nintedanib

Nintedanib

Trial Locations (1)

02186

Medicus Economics, LCC, Milton

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY